Rhopressa®

netarsudil dimesylate 0.02%
ophthalmic solution
Antiglaucoma
[ Rho kinase inhibitor, norepinephrine transporter inhibitor]
Indication

Indication

Indicated for lowering IOP with open-angle glaucoma or ocular hypertension
Mechanism of Action

Mechanism of Action

Rhopressa® is an effective inhibitor of Rho kinase and a noradrenaline transporter that may relax the trabecular meshwork, increase the outflow of aqueous humor, reduce scleral venous pressure, and directly decrease IOP.
Common quantities available

Available Quantities

2.5ml
Dosage

Dosage/Instructions

1 drop in the evening
Pregnancy & Nursing Data

Pregnancy & Nursing

Rat embryofetal lethality was shown at 126X normal human dose but not at 40X.
Pediatric Use

Pediatric Use

No studies
Warnings Tab

Contraindications, side effects, etc.

Warnings: May cause eye discomfort, redness, tearing, temporary blurred vision, eyelid redness, or corneal staining. Common side effects: Conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage.